Pioneering the discovery and development of novel cancer therapies.
Corporate Office
| SuperGen, Inc. | |
| 4140 Dublin Blvd. | |
| Suite 200 | |
| Dublin, CA 94568 | |
| Phone: | 925-560-0100 |
| Fax: | 925-560-0101 |
Primary IR Contact
| Timothy L. Enns | |
| Sr. Vice President, Corporate Communications and Business Development | |
| Phone: | 925-560-0100 |
| Fax: | 925-551-6491 |
| E-mail: | tenns@supergen.com |
Transfer Agent
| Mellon Investor Services, LLC | |
| 480 Washington Blvd. | |
| Jersey City, NJ 07310 | |
| Corporate Website: | www.melloninvestor.com |
Webmaster
| E-mail: | webmaster@supergen.com |
